FBInvestor
Stocks / Cyclacel Pharmaceuticals Inc
Institutional Ownership

Cyclacel Pharmaceuticals Inc

CUSIP 23254L207PFD CONV EX 6%BGMS.6.PERPQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon